A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer
Clinical trial NCT02091960 · COMPLETED
Trial details
- NCT number
- NCT02091960
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-05
- Primary completion
- 2017-02-28
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.